272 related articles for article (PubMed ID: 20484929)
1. Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia.
Katoh S; Nobumoto A; Matsumoto N; Matsumoto K; Ehara N; Niki T; Inada H; Nishi N; Yamauchi A; Fukushima K; Hirashima M
Int Arch Allergy Immunol; 2010; 153(3):294-302. PubMed ID: 20484929
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of antimicrobial peptides in bronchoalveolar lavage fluid in patients with chronic eosinophilic pneumonia.
Ashitani J; Matsumoto N; Nakazato M
Respiration; 2007; 74(1):69-75. PubMed ID: 16369124
[TBL] [Abstract][Full Text] [Related]
3. A specific elevation of RANTES in bronchoalveolar lavage fluids of patients with chronic eosinophilic pneumonia.
Kurashima K; Mukaida N; Fujimura M; Yasui M; Shinagawa T; Matsuda T; Ohmoto Y; Matsushima K
Lab Invest; 1997 Jan; 76(1):67-75. PubMed ID: 9010450
[TBL] [Abstract][Full Text] [Related]
4. Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.
Katoh S; Oomizu S; Niki T; Shimizu H; Obase Y; Korenaga M; Oka M; Hirashima M
Int Arch Allergy Immunol; 2012; 158 Suppl 1():58-65. PubMed ID: 22627368
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of CXCR3-expressing eosinophils and increased concentration of its ligands (IP10 and Mig) in bronchoalveolar lavage fluid of patients with chronic eosinophilic pneumonia.
Katoh S; Fukushima K; Matsumoto N; Ehara N; Matsumoto K; Yamauchi A; Hirashima M
Int Arch Allergy Immunol; 2005 Jul; 137(3):229-35. PubMed ID: 15956791
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of interleukin 33 (IL-33) in patients with eosinophilic pneumonia.
Mato N; Bando M; Kusano A; Hirano T; Nakayama M; Uto T; Nakaya T; Yamasawa H; Sugiyama Y
Allergol Int; 2013 Mar; 62(1):45-52. PubMed ID: 23000728
[TBL] [Abstract][Full Text] [Related]
7. Elevated concentrations of liver-expressed chemokine/CC chemokine ligand 16 in bronchoalveolar lavage fluid from patients with eosinophilic pneumonia.
Nureki S; Miyazaki E; Usagawa Y; Ueno T; Ando M; Takenaka R; Ito T; Ishii T; Kumamoto T
Int Arch Allergy Immunol; 2009; 150(3):282-90. PubMed ID: 19494526
[TBL] [Abstract][Full Text] [Related]
8. Predominant implication of IL-5 in acute eosinophilic pneumonia: comparison with chronic eosinophilic pneumonia.
Okubo Y; Horie S; Hachiya T; Momose T; Tsukadaira A; Takashi S; Suzuki J; Isobe M; Sekiguchi M
Int Arch Allergy Immunol; 1998 May; 116(1):76-80. PubMed ID: 9623513
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil transendothelial migration induced by the bronchoalveolar lavage fluid of acute eosinophilic pneumonia.
Nakagome K; Shoda H; Shirai T; Nishihara F; Soma T; Uchida Y; Sakamoto Y; Nagata M
Respirology; 2017 Jul; 22(5):913-921. PubMed ID: 28139852
[TBL] [Abstract][Full Text] [Related]
10. Increased serum ADAM8 concentration in patients with drug-induced eosinophilic pneumonia-ADAM8 expression depends on a the allergen route of entry.
Matsuno O; Ono E; Ueno T; Takenaka R; Nishitake T; Hiroshige S; Miyazaki E; Kumamoto T; Higuchi Y
Respir Med; 2010 Jan; 104(1):34-9. PubMed ID: 19625177
[TBL] [Abstract][Full Text] [Related]
11. Increased interleukin-5 levels in bronchoalveolar lavage fluid is a major factor for eosinophil accumulation in acute eosinophilic pneumonia.
Nakahara Y; Hayashi S; Fukuno Y; Kawashima M; Yatsunami J
Respiration; 2001; 68(4):389-95. PubMed ID: 11464086
[TBL] [Abstract][Full Text] [Related]
12. Involvement of galectin-9 in guinea pig allergic airway inflammation.
Yamamoto H; Kashio Y; Shoji H; Shinonaga R; Yoshimura T; Nishi N; Nabe T; Nakamura T; Kohno S; Hirashima M
Int Arch Allergy Immunol; 2007; 143 Suppl 1():95-105. PubMed ID: 17541286
[TBL] [Abstract][Full Text] [Related]
13. Elevated chemokine levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
Katoh S; Matsumoto N; Fukushima K; Mukae H; Kadota JI; Kohno S; Matsukura S
J Allergy Clin Immunol; 2000 Oct; 106(4):730-6. PubMed ID: 11031344
[TBL] [Abstract][Full Text] [Related]
14. Eotaxin and monocyte chemoattractant protein-1 in chronic eosinophilic pneumonia.
Tateno H; Nakamura H; Minematsu N; Amakawa K; Terashima T; Fujishima S; Luster AD; Lilly CM; Yamaguchi K
Eur Respir J; 2001 May; 17(5):962-8. PubMed ID: 11488333
[TBL] [Abstract][Full Text] [Related]
15. Elevated interleukin-18 levels in bronchoalveolar lavage fluid of patients with eosinophilic pneumonia.
Katoh S; Matsumoto N; Matsumoto K; Fukushima K; Matsukura S
Allergy; 2004 Aug; 59(8):850-6. PubMed ID: 15230818
[TBL] [Abstract][Full Text] [Related]
16. Reduced IgG levels found during acute eosinophilic pneumonia, which normalize during recovery from disease.
Matsuno O; Takenaka R; Hiroshige S; Ono E; Nishitake T; Ueno T; Miyazaki E; Kumamoto T
Respir Med; 2008 Jun; 102(6):899-903. PubMed ID: 18314320
[TBL] [Abstract][Full Text] [Related]
17. Possible Role of IL-25 in Eosinophilic Lung Inflammation in Patients with Chronic Eosinophilic Pneumonia.
Katoh S; Ikeda M; Matsumoto N; Shimizu H; Abe M; Ohue Y; Mouri K; Kobashi Y; Nakazato M; Oka M
Lung; 2017 Dec; 195(6):707-712. PubMed ID: 28875265
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
19. Infiltrating eosinophils and eotaxin: their association with idiopathic eosinophilic esophagitis.
Fujiwara H; Morita A; Kobayashi H; Hamano K; Fujiwara Y; Hirai K; Yano M; Naka T; Saeki Y
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):429-32. PubMed ID: 12392390
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
